These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 7938460
1. Effects of gamma rays, ultraviolet radiation, sunlight, microwaves and electromagnetic fields on gene expression mediated by human immunodeficiency virus promoter. Libertin CR, Panozzo J, Groh KR, Chang-Liu CM, Schreck S, Woloschak GE. Radiat Res; 1994 Oct; 140(1):91-6. PubMed ID: 7938460 [Abstract] [Full Text] [Related]
4. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons. Miller SC, Taylor A, Watanabe K, Mok K, Torti FM. Exp Cell Res; 1997 Jan 10; 230(1):9-21. PubMed ID: 9013701 [Abstract] [Full Text] [Related]
5. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein. Zhang JL, Sharma PL, Crumpacker CS. Virology; 2000 Mar 15; 268(2):251-63. PubMed ID: 10704334 [Abstract] [Full Text] [Related]
6. Retinoblastoma gene inhibits transactivation of HIV-LTR linked gene expression upon co-transfection in He La cells. Prasad MV, Shanmugam G. Biochem Mol Biol Int; 1993 Jan 15; 29(1):57-62. PubMed ID: 8490568 [Abstract] [Full Text] [Related]
7. A quantitative bioassay for HIV-1 gene expression based on UV activation: effect of glycyrrhizic acid. Cherng JM, Lin HJ, Hsu YH, Hung MS, Lin JC. Antiviral Res; 2004 Apr 15; 62(1):27-36. PubMed ID: 15026199 [Abstract] [Full Text] [Related]
8. In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. Cavard C, Zider A, Vernet M, Bennoun M, Saragosti S, Grimber G, Briand P. J Clin Invest; 1990 Oct 15; 86(4):1369-74. PubMed ID: 2120288 [Abstract] [Full Text] [Related]
9. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B. Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770 [Abstract] [Full Text] [Related]
10. X-rays-induced secretion of cellular factor(s) that enhance(s) HIV-1 promoter transcription in various non-irradiated transfected cell lines. Faure E. Cell Mol Biol (Noisy-le-grand); 1998 Dec 01; 44(8):1275-92. PubMed ID: 9874515 [Abstract] [Full Text] [Related]
11. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C, Rosenberg M. Nature; 1988 May 05; 333(6168):78-81. PubMed ID: 3129661 [Abstract] [Full Text] [Related]
12. Transactivation of human immunodeficiency virus by herpesviruses. Rando RF, Pellett PE, Luciw PA, Bohan CA, Srinivasan A. Oncogene; 1987 Mar 05; 1(1):13-8. PubMed ID: 2830574 [Abstract] [Full Text] [Related]
13. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity. Nahreini P, Mathews MB. Virology; 1997 Jul 21; 234(1):42-50. PubMed ID: 9234945 [Abstract] [Full Text] [Related]
14. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation. Yurochko AD, Huong SM, Huang ES. J Hum Virol; 1999 Jul 21; 2(2):81-90. PubMed ID: 10225210 [Abstract] [Full Text] [Related]
15. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies. Mukhtar M, Duan L, Bagasra O, Pomerantz RJ. Gene Ther; 1996 Aug 21; 3(8):725-30. PubMed ID: 8854098 [Abstract] [Full Text] [Related]
16. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression. Mitra D, Sikder SK, Laurence J. Virology; 1995 Dec 20; 214(2):512-21. PubMed ID: 8553553 [Abstract] [Full Text] [Related]
17. The effects of cisplatin and methotrexate on the expression of human immunodeficiency virus type 1 long terminal repeat. Panozzo J, Panozzo J, Akan E, Libertin C, Woloschak GE. Leuk Res; 1996 Apr 20; 20(4):309-17. PubMed ID: 8642842 [Abstract] [Full Text] [Related]
19. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3. Nevado J, Tenbaum SP, Castillo AI, Sánchez-Pacheco A, Aranda A. J Mol Endocrinol; 2007 Jun 20; 38(6):587-601. PubMed ID: 17556530 [Abstract] [Full Text] [Related]
20. The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5' long terminal repeat. Lin JC. Biochem Biophys Res Commun; 1993 Aug 31; 195(1):242-9. PubMed ID: 8395825 [Abstract] [Full Text] [Related] Page: [Next] [New Search]